Following these proceedings, A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. B. Riley Securities began covering TFFP with “Buy” recommendation on December 07, 2020. Maxim Group maintained its rating on August 17, 2020. It rated TFFP as “a Buy”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of TFFP
On Tuesday, Tff Pharmaceuticals Inc [NASDAQ:TFFP] saw its stock jump 8.74% to $0.40. Over the last five days, the stock has lost -78.13%. Tff Pharmaceuticals Inc shares have fallen nearly -94.36% since the year began. Nevertheless, the stocks have fallen -94.44% over the past one year. While a 52-week high of $11.00 was reached on 03/20/24, a 52-week low of $0.27 was recorded on 11/15/24. SMA at 50 days reached $1.9560, while 200 days put it at $3.1168.
Levels Of Support And Resistance For TFFP Stock
The 24-hour chart illustrates a support level at 0.3172, which if violated will result in even more drops to 0.2386. On the upside, there is a resistance level at 0.4872. A further resistance level may holdings at 0.5786. The Relative Strength Index (RSI) on the 14-day chart is 24.25, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.1368, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.75%. Stochastics %K at 3.67% indicates the stock is a buying.
How much short interest is there in Tff Pharmaceuticals Inc?
A steep rise in short interest was recorded in Tff Pharmaceuticals Inc stocks on 2024-10-31, growing by 40670.0 shares to a total of 0.17 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.13 million shares. There was a rise of 23.65%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 08, 2020 when Maxim Group began covering the stock and recommended ‘”a Buy”‘ rating along with a $12 price target.
